A total of 54 Private Equity/Venture Financing deals (pending and completed) were announced in the Global Pharmaceuticals sector driven by Artificial Intelligence, in the last twelve months resulting in a total deal value of over $2,467.8 million. In the LTM period, June 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $49.0 million, resulting in an average deal value of $58.7 million during that month. On the other hand, the month of December 2021 was the most prolific in terms of deal volume, recording a total of 8 deals being made, with average deal value of $29.2 million during that month.
Of the 54 deals, the deal secured between 5Y Capital; Orbimed Advisors LLC; RRJ Capital; Sequoia Capital Operations LLC; Sino Biopharmaceutical Ltd and XtalPi Inc, was the largest Private Equity/Venture Financing deal in the Global Pharmaceuticals sector driven by Artificial Intelligence, which was valued at $400.0 million and was completed on August 11, 2021. The second-largest deal was between B Capital Group Management, L.P.; Baidu Ventures; Bold Capital Partners; CITIC Industrial Investment Fund Management Co Ltd; Deerfield Management Co LP; Eight Roads Ventures; Formic Ventures; Lake Bleu Capital; Lilly Asia ventures; Maison Capital Group; Mirae Asset Capital Co Ltd; Orbimed Advisors LLC; Pavilion Capital Partners LLC; President International Development Corporation; Qiming Venture Partners; Sage Partners; Sequoia Capital China; Sinovation Ventures; Warburg Pincus LLC and InSilico Medicine, while the third-largest deal was between Ally Bridge Group; ARCH Venture Partners LP; ArrowMark Partners; Deep Track Capital LP; Great Point Ventures Fund; Illumina Ventures; Janus Henderson Investors; Logos Global Management LLC; Ono Venture Investment Inc; Piper Heartland Healthcare Capital, LLC; Ridgeback Capital Investment LLC; Section 32; Surveyor Capital Ltd; T Rowe Price Associates Inc; Tao Capital Partners; TCG Crossover; Tekla Capital Management LLC; Temasek Holdings (Private) Ltd; Vertex Pharmaceuticals Inc; Woodline Partners and Arbor Biotechnologies Inc. The B Capital Group Management, L.P.; Baidu Ventures; Bold Capital Partners; CITIC Industrial Investment Fund Management Co Ltd; Deerfield Management Co LP; Eight Roads Ventures; Formic Ventures; Lake Bleu Capital; Lilly Asia ventures; Maison Capital Group; Mirae Asset Capital Co Ltd; Orbimed Advisors LLC; Pavilion Capital Partners LLC; President International Development Corporation; Qiming Venture Partners; Sage Partners; Sequoia Capital China; Sinovation Ventures; Warburg Pincus LLC-InSilico Medicine deal and the Ally Bridge Group; ARCH Venture Partners LP; ArrowMark Partners; Deep Track Capital LP; Great Point Ventures Fund; Illumina Ventures; Janus Henderson Investors; Logos Global Management LLC; Ono Venture Investment Inc; Piper Heartland Healthcare Capital, LLC; Ridgeback Capital Investment LLC; Section 32; Surveyor Capital Ltd; T Rowe Price Associates Inc; Tao Capital Partners; TCG Crossover; Tekla Capital Management LLC; Temasek Holdings (Private) Ltd; Vertex Pharmaceuticals Inc; Woodline Partners-Arbor Biotechnologies Inc deal were valued at $255.0 million and $215.0 million, respectively. The fourth-largest deal was between Oaktree Capital Management LP; Qatar Investment Authority-BioXcel Therapeutics Inc valued at $125.0 million, whereas the deal between Boxer Capital LLC; GV Capital; Lightspeed Venture Partners - US; Polaris Partners LLC; Samsara BioCapital LLC; Timothy A. Springer-Seismic Therapeutic Inc valued at $101.0 million was the fifth-largest deal.
Cumulatively, the top five deals amounted to $1,096 million and accounted for nearly 44.41% of the total deals (by value) announced during the last twelve months. By region, North America accounted for 80.66% of the total Private Equity/Venture Financing deals done globally, and recorded a total deal value of $1,990.6 million, which accounted for 64.81% of the total deal size on a global scale.
United States of America
China
Switzerland
United States of America
United States of America
United States of America
United States of America
Germany
France
Switzerland
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward